- Home
- BANX vs QSI Comparison
BANX vs QSI Comparison
Compare BANX & QSI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | BANX | QSI |
|---|---|---|
| Founded | N/A | 2013 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Trusts Except Educational Religious and Charitable | Biotechnology: Pharmaceutical Preparations |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 202.4M | 165.6M |
| IPO Year | 2013 | 2020 |
Fundamental Metrics
Financial Performance| Metric | BANX | QSI |
|---|---|---|
| Price | $20.25 | $1.35 |
| Analyst Decision | | Buy |
| Analyst Count | 0 | 3 |
| Target Price | N/A | ★ $2.28 |
| AVG Volume (30 Days) | 38.3K | ★ 4.6M |
| Earning Date | 01-01-0001 | 11-04-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 28.17 |
| EPS | ★ N/A | N/A |
| Revenue | N/A | ★ $2,436,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | $406.32 |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $18.45 | $0.69 |
| 52 Week High | $22.50 | $3.10 |
Technical Indicators
Market Signals| Indicator | BANX | QSI |
|---|---|---|
| Relative Strength Index (RSI) | 44.83 | 77.22 |
| Support Level | $19.33 | $1.13 |
| Resistance Level | $21.28 | N/A |
| Average True Range (ATR) | 0.51 | 0.09 |
| MACD | -0.12 | 0.07 |
| Stochastic Oscillator | 47.30 | 77.16 |
Price Performance
Historical ComparisonAbout BANX ArrowMark Financial Corp.
ArrowMark Financial Corp is a non-diversified, closed-end management investment company. The Fund's objective is to provide stockholders with current income, and to a lesser extent capital appreciation. The company's investments in various portfolios such as debt securities, Trust Preferred and Preferred Securities, preferred securities, exchange-traded funds, money market funds and others.
About QSI Quantum-Si Incorporated
Quantum-Si Inc is a life sciences company focused on proteomics research and analytical technologies. It develops single-molecule detection platforms designed to enable next-generation protein sequencing (NGPS) and large-scale protein analysis. Its technology supports massively parallel sequencing of proteins and can also be applied to the study of nucleic acids, providing tools for researchers and clinical applications in molecular analysis. The company's revenue is derived from sales of products and services.